ArticleResearch square2025
Epidemiological Analysis of Obesity-related co-morbidities and mortality among post- menopausal women diagnosed with endometrial cancer: A Randomized Controlled Trial.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00000611 (Women's Health Initiative), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Women's Health Initiative (WHI)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Objective: Obesity is a risk factor for endometrial cancer (EC). Five-year survival is over 80%; however, mortality rates have increased in recent years. Post-menopausal women with EC frequently present with obesity-related comorbidities or develop comorbidities after diagnosis. Survival may vary related to this comorbidity burden. This analysis describes modifiable comorbidities (diabetes, cardiovascular disease, hypertension, and fractures) among post-menopausal EC survivors and evaluates the relationship between obesity-related comorbidities and mortality after an endometrial cancer diagnosis. Methods: Epidemiological analysis of overall mortality in relation to incidence of obesity-related comorbidity (obesity, diabetes, cardiovascular disease, hypertension and fractures) after EC diagnosis. The participants are Post-menopausal women from 40 clinical sites across the U.S. participating in the Women's Health Initiative (WHI) observational or clinical trials and diagnosed with incident EC during follow-up. Adjusted Cox proportional hazards regression models for incident EC were used to evaluate the relationship between comorbidities and all-cause mortality. Results: 1661 incident cases of EC were identified. Mortality rates were 55.5% for women with EC. Prevalence increased from baseline to 18 y follow-up for each comorbidity. Regression analyses for incident EC indicated that severe obesity HR (95% CI): 2.13 (1.52, 2.97), cardiovascular disease, 1.50 (1.26, 1.78), and fracture, 1.17 (1.07, 1.27) were associated with greater overall mortality. Conclusions: Obesity-associated comorbidities are common and are associated with greater mortality in postmenopausal women diagnosed with endometrial cancer. Interventions to modify risk for comorbidity in EC survivors may improve survival and should be evaluated. Clinical Trial Registration: NCT00000611.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.